Literature DB >> 12820354

Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer.

Alexander Mustea1, Jalid Sehouli, Dominique Könsgen, Dirk Stengel, Dumitru Sofroni, Werner Lichtenegger.   

Abstract

BACKGROUND: Several studies suggest that immunological components play a key role in the development of cervical cancer. Polymorphism in the IL-1 RA gene was associated with various malignant diseases. Data is lacking for cervical cancer.
MATERIALS AND METHODS: In a prospective study we analysed the polymorphism of IL-1RA in 113 women with cervical cancer and 107 with benign diseases. Genomic DNA fragments were amplified by PCR.
RESULTS: The distribution of genotype frequencies was different between the study and control group with respect to allele 2 heterozygotes (24.8% vs. 13.1%; p = 0.04) but not in the frequencies of allele 1/3 and homozygous allele 2. There were no differences between IL-1 RA 1/2 polymorphism and all other alleles in tumour stage, grading, recurrence status and age.
CONCLUSION: This data supports the role for allele 2 of the gene encoding for IL1-RA as a genetic determinant of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12820354

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  A polymorphism at miRNA-122-binding site in the IL-1α 3'UTR is associated with risk of epithelial ovarian cancer.

Authors:  Zhu Zhang; Bin Zhou; Qianqian Gao; Yuke Wu; Kui Zhang; Yan Pu; Yaping Song; Lin Zhang; Mingrong Xi
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

2.  IL-1RN VNTR polymorphism and genetic susceptibility to cervical cancer in Portugal.

Authors:  Hugo Sousa; Alexandra M Santos; Raquel Catarino; Daniela Pinto; José Moutinho; Paulo Canedo; José Carlos Machado; Rui Medeiros
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

3.  Interleukin-1 Gene Cluster Polymorphisms and its Haplotypes may Predict the Risk to Develop Cervical Cancer in Tunisia.

Authors:  Sabrina Zidi; Ikram Sghaier; Ferjeni Zouidi; Amira Benahmed; Mouna Stayoussef; Radhia Kochkar; Ezzedine Gazouani; Amel Mezlini; Besma Yacoubi-Loueslati
Journal:  Pathol Oncol Res       Date:  2015-04-30       Impact factor: 3.201

4.  A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer.

Authors:  Yang Zhang; Erich M Sturgis; Yan Sun; Chuanzheng Sun; Qingyi Wei; Zhigang Huang; Guojun Li
Journal:  Eur J Cancer       Date:  2015-05-14       Impact factor: 9.162

5.  Circulating IL-1beta levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women.

Authors:  Nianfeng Qian; Xiaojun Chen; Suping Han; Fulin Qiang; Guangfu Jin; Xiaoyi Zhou; Jing Dong; Xinru Wang; Hongbing Shen; Zhibin Hu
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-11       Impact factor: 4.553

6.  Interleukin-1 beta-511 polymorphism and risk of cervical cancer.

Authors:  Sokbom Kang; Jae Weon Kim; Noh Hyun Park; Yong Sang Song; Sang Yoon Park; Soon Beom Kang; Hyo Pyo Lee
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

7.  Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents.

Authors:  Staci L Sudenga; Howard W Wiener; Aditi Shendre; Craig M Wilson; Jianming Tang; Sadeep Shrestha
Journal:  Hum Immunol       Date:  2013-08-21       Impact factor: 2.850

8.  Interleukin-1 Receptor Antagonist and Interleukin-4 Genes Variable Number Tandem Repeats Are Associated with Adiposity in Malaysian Subjects.

Authors:  Yung-Yean Kok; Hing-Huat Ong; Yee-How Say
Journal:  J Obes       Date:  2017-02-15

9.  Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review.

Authors:  S P Balasubramanian; I A F Azmy; S E Higham; A G Wilson; S S Cross; A Cox; N J Brown; M W Reed
Journal:  BMC Cancer       Date:  2006-07-14       Impact factor: 4.430

10.  A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer.

Authors:  Chengyuan Wang; Erich M Sturgis; Xingming Chen; Qingyi Wei; Guojun Li
Journal:  Oncotarget       Date:  2016-06-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.